CardioRisk Calculator
CardioRisk Calculator is made and published by The University of British Columbia - Okanagan. AppBrain is an independent app data site and isn't affiliated with The University of British Columbia - Okanagan. The app name, icon, screenshots and description belong to The University of British Columbia - Okanagan and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- October 21, 2023
Rankings
App Store top chartsApp Store Rankings for CardioRisk Calculator
Competitors
Similar apps and more from The University of British Columbia - OkanaganAlternatives to CardioRisk Calculator
Releases
Updates seen on the App Store- Version
- 1.6.9
- Launched
- December 2010
No changelog data
User feedback
Ratings and reviews on the App StoreComments on CardioRisk Calculator for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 1.51 MB
- Content rating
- High
Technologies used by CardioRisk Calculator
About the app and developer
About CardioRisk Calculator
CardioRisk Calculator is a medical app developed by The University of British Columbia - Okanagan.
User Ratings
The app has no ratings yet.
App Information
CardioRisk Calculator is freely available from the App Store. The app size is 1.51 MB. The latest version available is 1.6.9. The last update was on October 21, 2023.
Technical Requirements
The app has a content rating of High Maturity. The app has been available on the App Store since December 2010.
Developer information for The University of British Columbia - Okanagan
Store listing
By The University of British Columbia - Okanagan, from the App Store
Description by The University of British Columbia - Okanagan Written by the developer, not by AppBrain. Click to read.
CardioRisk Calculator™ provides:
-quick calculations on % LDL-C reductions
-concise drug dosage information
-clear snapshot of a patient's CV risk
-options to bring lipid levels to target
-easy identification of familial hypercholesterolemia
This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.
Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):
- Amgen Canada
- Bayer Inc
- Boehringer Ingelheim (Canada) Ltd
- FH Canada
- HLS Therapeutics
- Janssen Inc
- Novo Nordisk Canada
- Sanofi Canada